Shares of HelloFresh SE (OTCMKTS:HLFFF – Get Rating) have been assigned a consensus rating of "Hold" from the nine brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $45.67.
A number of brokerages recently issued reports on HLFFF. Morgan Stanley dropped their price objective on HelloFresh from €32.00 ($34.41) to €30.00 ($32.26) and set an "equal weight" rating on the stock in a report on Wednesday, January 4th. JPMorgan Chase & Co. cut HelloFresh from a "neutral" rating to an "underweight" rating in a report on Friday, February 10th. Deutsche Bank Aktiengesellschaft lowered their price target on HelloFresh from €54.00 ($58.06) to €47.00 ($50.54) in a report on Monday, October 31st. Barclays cut HelloFresh from an "overweight" rating to an "equal weight" rating in a report on Monday, January 30th. Finally, Credit Suisse Group cut HelloFresh from an "outperform" rating to a "neutral" rating in a report on Wednesday, February 8th.
Get HelloFresh alerts:HelloFresh Trading Up 0.1 %
HLFFF stock opened at $23.19 on Friday. HelloFresh has a fifty-two week low of $20.32 and a fifty-two week high of $53.00. The stock has a fifty day moving average of $24.68 and a 200-day moving average of $24.75.
About HelloFresh
(Get Rating)
HelloFresh SE engages in the provision of personalized meal solutions. It operates through the following segments: United States of America (USA), International, and Holding. The International segment comprises Australia, Austria, Belgium, Canada, Germany, the Netherlands, Switzerland, and the United Kingdom.
Read More
- Get a free copy of the StockNews.com research report on HelloFresh (HLFFF)
- MarketBeat Week in Review – 2/13 – 2/17
- Deere Stock Raises Outlook and is Ready to Power Higher
- DraftKings Crowning Achievement: Leverage
- Tesla Stock Comeback Is Picking Up Steam
- How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
Receive News & Ratings for HelloFresh Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HelloFresh and related companies with MarketBeat.com's FREE daily email newsletter.